Oral-Facial Aspects of Osteogenesis Imperfecta - Osteogenesis Imperfecta - page 296

[12] O'Connell AC, Marini JC. Evaluation of oral problems in an
osteogenesis imperfecta population. Oral Surg Oral Med Oral
Pathol Oral Radiol Endod 1999;87(2):189-96.
[13] Hartsfield Jr JK, Schwartz S. Dental care for people with osteo-
genesis imperfecta, < http://www.oif.org/site/PageServer?pag
ename=Dental2013 >; 2007.
[14] Waltimo J, Ojanotko-Harri A, Lukinmaa PL. Mild forms of
dentinogenesis imperfecta in association with osteogenesis
imperfecta as characterized by light and transmission electron
microscopy. J Oral Pathol Med 1996;25(5):256-64.
[15] Hu JC, Simmer JP. Developmental biology and genetics of den-
tal malformations. Orthod Craniofac Res 2007;10(2):45-52.
[16] Listgarten M. Osteogenesis imperfecta with dentinogenesis
imperfecta. J Can Dent Assoc (Tor) 1960;26:412-6.
[17] Beertsen W, McCulloch CA, Sodek J. The periodontal ligament:
a unique, multifunctional connective tissue. Periodontol 2000
1997;13:20-40.
[18] Jensen BL, Kreiborg S. Development of the dentition in cleido-
cranial dysplasia. J Oral Pathol Med 1990;19(2):89-93.
[19] Wise GE, King GJ. Mechanisms of tooth eruption and orthodon-
tic tooth movement. J Dent Res 2008;87(5):414-34.
[20] Wise GE, Frazier-Bowers S, D'Souza RN. Cellular, molecular,
and genetic determinants of tooth eruption. Crit Rev Oral Biol
Med 2002;13(4):323-34.
[21] Decker E, Stellzig-Eisenhauer A, Fiebig BS, et al. PTHR1 loss-of-
function mutations in familial, nonsyndromic primary failure of
tooth eruption. Am J Hum Genet 2008;83(6):781-6.
[22] Stellzig-Eisenhauer A, Decker E, Meyer-Marcotty P, et al.
Primary failure of eruption (PFE) - clinical and molecular genet-
ics analysis. J Orofac Orthop 2010;71(1):6-16.
[23] Frazier-Bowers SA, Simmons D, Wright JT, Profit WR,
Ackerman JL. Primary failure of eruption and PTH1R: the
importance of a genetic diagnosis for orthodontic treatment
planning. Am J Orthod Dentofacial Orthop 2010;137(2) 160 e1-7;
discussion-1.
[24] Ahmad S, Bister D, Cobourne MT. The clinical features and
aetiological basis of primary eruption failure. Eur J Orthod
2006;28(6):535-40.
[25] Antoniazzi F, Mottes M, Fraschini P, Brunelli PC, Tatò L.
Osteogenesis imperfecta: practical treatment guidelines. Pediatr
Drugs 2000;2(6):465-88.
[26] Devogelaer JP. New uses of bisphosphonates: osteogenesis
imperfecta. Curr Opin Pharmacol 2002;2(6):748-53.
[27] Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G,
Travers R. Cyclic administration of pamidronate in chil-
dren with severe osteogenesis imperfecta. N Engl J Med
1998;339(14):947-52.
[28] Grier RL, Wise G. Inhibition of tooth eruption in the rat by a
bisphosphonate. J Dent Res 1998;77(1):8.
[29] Kamoun Goldrat A, Ginisty D, Merrer ML. Effects of bisphos-
phonates on tooth eruption in children with osteogenesis imper-
fecta. Eur J Oral Sci 2008;116(3):195-8.
[30] Sheppard GB, Hartsfield Jr JK, Kowolik J, Ofner S, Peacock M,
DiMeglio LA. The effects of osteogenesis imperfecta and
bisphosphonate therapy on dental development. Unpublished
data; 2007.

[34] Malmgren B, Åström E, Söderhäll S. No osteonecrosis in jaws

of young patients with osteogenesis imperfecta treated with
bisphosphonates. J Oral Pathol Med 2008;37(4):196-200.

[35] Milano M, Wright T, Loechner KJ. Dental implications of osteo-

genesis imperfecta: treatment with IV bisphosphonate: report of
a case. Pediatr Dent 2011;33(4):349-52.

[36] Sæves R, Wekre LL, Ambjørnsen E, Axelsson S, Nordgarden H,

Storhaug K. Oral indings in adults with osteogenesis imper-
fecta. Spec Care Dentist 2009;29(2):102-8.

[37] Zola MB. Staged sinus augmentation and implant placement in

a patient with osteogenesis imperfecta. J Oral Maxillofac Surg
2000;58(4):443-7.

[38] Lee CY, Ertel SK. Bone graft augmentation and dental implant

treatment in a patient with osteogenesis imperfecta: review of
the literature with a case report. Implant Dent 2003;12(4):291-5.

[39] Binger T, Rücker M, Spitzer WJ. Dentofacial rehabilitation by

osteodistraction, augmentation and implantation despite osteo-
genesis imperfecta. Int J Oral Maxillofac Surg 2006;35(6):559-62.

[40] Prabhu N, Duckmanton N, Stevenson AR, Cameron A. The

placement of osseointegrated dental implants in a patient with
type IV B osteogenesis imperfecta: a 9-year follow-up. Oral Surg
Oral Med Oral Pathol Oral Radiol Endod 2007;103(3):349-54.

[41] Payne MA, Postlethwaite KR, Smith DG, Nohl FS. Implant-

supported rehabilitation of an edentate patient with osteogen-
esis imperfecta: a case report. Int J Oral Maxillofac Implants
2008;23(5):947-52.

[42] Wannfors K, Johansson C, Donath K. Augmentation of the mandi-

ble via a “tent-pole” procedure and implant treatment in a patient
with type III osteogenesis imperfecta: clinical and histologic con-
siderations. Int J Oral Maxillofac Implants 2009;24(6):1144-8.

[43] Jensen JL, Brox HT, Storhaug K, Ambjørnsen E, Støvne SA,

Bjørnland T. Dental implants in patients with osteogenesis
imperfecta: a retrospective and prospective study with review of
the literature. Oral Surg 2011;4(3):105-14.

[44] Grant BT, Amenedo C, Freeman K, Kraut RA. Outcomes of plac-

ing dental implants in patients taking oral bisphosphonates: a
review of 115 cases. J Oral Maxillofac Surg 2008;66(2):223-30.

[45] Magopoulos C, Karakinaris G, Telioudis Z, et al. Osteonecrosis

of the jaws due to bisphosphonate use. A review of 60 cases and
treatment proposals. Am J Otolaryngol 2007;28(3):158-63.

[46] Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL.

Osteonecrosis of the jaws associated with the use of bisphos-
phonates: a review of 63 cases. J Oral Maxillofac Surg 2004;62(5):
527-34.

[47] Ruggiero SL, Dodson TB, Assael LA, et al. American association

of oral and maxillofacial surgeons position paper on bisphos-
phonate-related osteonecrosis of the jaws - 2009 update. J Oral
Maxillofac Surg 2009;67(5 Suppl):2-12.

[48] Hartsield JK, Hohlt WF, Roberts WE. Orthodontic treatment

and orthognathic surgery for patients with osteogenesis imper-
fecta. Semin Orthod 2006;12:254-71.

[49] Cheung MS, Arponen H, Roughley P, et al. Cranial base abnor-

malities in osteogenesis imperfecta: phenotypic and genotypic
determinants. J Bone Miner Res 2011;26(2):405-13.

[50] Glorieux FH. Osteogenesis imperfecta. Best Pract Res Clin

Rheumatol 2008;22(1):85-100.

[31] Igar K, Adachi H, Mitani H, Shinoda H. Inhibitory effect of the

topical administration of a bisphosphonate (risedronate) on
root resorption incident to orthodontic tooth movement in rats.
J Dent Res 1996;75(9):1644.

[51] Kovero O, Pynnönen S, Kuurila-Svahn K, Kaitila I, Waltimo-

Sirén J. Skull base abnormalities in osteogenesis imperfecta: a
cephalometric evaluation of 54 patients and 108 control volun-
teers. J Neurosurg 2006;105(3):361-70.

[32] Liewehr FR, Craft DW, Primack PD, et al. Effect of bisphospho-

nates and gallium on dentin resorption in vitro. Dent Traumatol
2006;11(1):20-6.

[52] Waltimo-Sirén J, Kolkka M, Pynnönen S, Kuurila K, Kaitila I,

Kovero O. Craniofacial features in osteogenesis imperfecta: a
cephalometric study. Am J Med Genet A 2005;133(2):142-50.

[33] Schwartz S, Joseph C, Iera D, Vu DD. Bisphosphonates, osteo-

necrosis, osteogenesis imperfecta and dental extractions: a case
series. J Can Dent Assoc (Tor) 2008;74(6):537-42.

[53] Jensen BL, Lund AM. Osteogenesis imperfecta: clinical, cephalo-

metric, and biochemical investigations of OI types I, III, and IV.
J Craniofac Genet Dev Biol 1997;17(3):121.